文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年慢病共病管理

衰弱与痴呆的关联及衰弱对降压治疗预防痴呆效果的影响

Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults.
PubMed 文献 · Age Ageing · 2026-01-01

基于Systolic Hypertension in the Elderly Program试验数据,构建含55项健康缺陷的基线衰弱指数(FI),纳入4692例老年单纯收缩期高血压患者。中位随访4.4年发生81例痴呆,FI每增加1个标准差(0.061)痴呆风险升高33%(OR 1.33,95%CI 1.08-1.64);

要点

  • 衰弱指数每升高1个标准差,痴呆风险增加33%(OR 1.33,95%CI 1.08-1.64)。
  • 仅最低衰弱四分位组显示降压治疗降低痴呆风险(OR 0.19,95%CI 0.04-0.94)。

核心结论

  • 在单纯收缩期高血压患者中,衰弱可能是痴呆的危险因素,且衰弱水平升高可能减弱降压治疗降低痴呆风险的效果。

研究设计与样本

  • 基于Systolic Hypertension in the Elderly Program试验数据的分析,构建含55项健康缺陷的基线衰弱指数(FI)。
  • 纳入4692例参与者,平均年龄72.1岁,女性占56.8%,FI中位数0.127(四分位区间0.091-0.173)。
  • 中位随访4.4年,发生81例痴呆,采用多项回归模型分析。

主要发现

  • FI每增加1个标准差(0.061),痴呆风险升高33%(OR 1.33,95%CI 1.08-1.64),校正年龄、性别、种族、教育程度和治疗组。

临床怎么用

  • 对老年高血压患者评估衰弱水平有助于识别痴呆高风险个体。
  • 衰弱程度较高的患者,降压治疗预防痴呆的获益可能减弱,需个体化权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between frailty and dementia risk in hypertensive patients remains unclear, as does the impact of frailty on the effectiveness of antihypertensive treatment in preventing dementia. METHODS: Using data from the Systolic Hypertension in the Elderly Program trial, a baseline frailty index (FI) including 55 health deficits was constructed. Multinomial regression models were used to examine the association between frailty and dementia, as well as to examine whether the impact of antihypertensive treatment on the risk of dementia was modified by baseline FI. RESULTS: A total of 4692 participants (mean age: 72.1 years, 56.8% female) were included with a median (inter-quartile interval) FI of 0.127 (0.091-0.173). During a median follow-up of 4.4 years, 81 dementia cases occurred. Each SD (0.061) increase in FI was associated with a 33% higher risk of dementia [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.08-1.64], after adjusting for age, sex, race, education and treatment group. This association differed between the active treatment group (OR: 1.57; 95% CI: 1.16-2.11) and the placebo group (OR: 1.17; 95% CI: 0.87-1.56), with a P for interaction = .049. Correspondingly, in the lowest FI quarter, antihypertensive treatment reduced dementia risk (OR: 0.19, 95% CI: 0.04-0.94), an effect not observed in higher FI quarters (interaction P = .058). CONCLUSION: In patients with isolated systolic hypertension, frailty may serve as a risk factor for dementia, and elevated levels of frailty may attenuate the effectiveness of antihypertensive treatment in reducing dementia risk.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Chen L, You S, Ee N, et al. Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults. Age Ageing. 2026. PMID: 41739751. doi:10.1093/ageing/afag037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。